Market Indices
Sector Heatmap
CYTK — Cytokinetics Inc.
NasdaqCytokinetics Inc.
- O
- 66.45
- H
- 66.91
- L
- 64.49
- V
- 2.47M
CYTK — Latest News & Headlines
13 StoriesCytokinetics, Incorporated (CYTK) stock price, news, quote and history - Yahoo Finance UK
Cytokinetics, Incorporated (CYTK) stock price, news, quote and history Yahoo Finance UK
Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cytokinetics, Incorporated (CYTK) Stock Price, News, Quote & History Yahoo! Finance Canada
A new study aims to enroll about 400 adults to assess a heart drug in everyday care. - Stock Titan
A new study aims to enroll about 400 adults to assess a heart drug in everyday care. Stock Titan
Is Real World Study Launch Altering The Investment Case For Cytokinetics (CYTK)? - Simply Wall Street
Is Real World Study Launch Altering The Investment Case For Cytokinetics (CYTK)? Simply Wall Street
Cytokinetics (CYTK) Insider Trading Activity 2026 $CYTK - MarketBeat
Cytokinetics (CYTK) Insider Trading Activity 2026 $CYTK MarketBeat
Understanding the Setup: (CYTK) and Scalable Risk - news.stocktradersdaily.com
Understanding the Setup: (CYTK) and Scalable Risk news.stocktradersdaily.com
Cytokinetics Announces Four Presentations at HFSA 2026 Highlighting Aficamten Data in Hypertrophic Cardiomyopathy - quiverquant.com
Cytokinetics Announces Four Presentations at HFSA 2026 Highlighting Aficamten Data in Hypertrophic Cardiomyopathy quiverquant.com
Cytokinetics (CYTK) Launches ASPEN-HCM Study to Evaluate Myqorzo in Obstructive Hypertrophic Cardiomyopathy - gurufocus.com
Cytokinetics (CYTK) Launches ASPEN-HCM Study to Evaluate Myqorzo in Obstructive Hypertrophic Cardiomyopathy gurufocus.com
Cytokinetics CEO Robert Blum sells $490,949 in stock - Investing.com
Cytokinetics CEO Robert Blum sells $490,949 in stock Investing.com
Cytokinetics, Incorporated (CYTK) stock price, news, quote and history - Yahoo Finance Singapore
Cytokinetics, Incorporated (CYTK) stock price, news, quote and history Yahoo Finance Singapore
Cytokinetics (CYTK) Pullback Puts Its Heart Drug Valuation Story Back In Focus - Simply Wall Street
Cytokinetics (CYTK) Pullback Puts Its Heart Drug Valuation Story Back In Focus Simply Wall Street
Cytokinetics (CYTK) Grinds Higher: Shares Trade Near $68 as Biotech Sentiment Steadies - Put Flow Alert - dars.gov.et
Cytokinetics (CYTK) Grinds Higher: Shares Trade Near $68 as Biotech Sentiment Steadies - Put Flow Alert dars.gov.et
Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story? - Yahoo Finance
Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story? Yahoo Finance